- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 23-01-2026: Press Release
23-01-2026 | 05:45 pm
23-01-2026 | 05:45 pm
Zydus's Ankleshwar Unit-2 USFDA inspection concluded with 3 observations, with no data integrity issues. This is a positive for operations. The company will address findings promptly, aiming to mitigate potential impact.
No comments yet. Be the first to comment!